These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33883369)

  • 1. [Influences of Tumor Volume and FWHM of the Water Peak and T
    Enoki T; Jomoto W; Yamano T; Kotoura N
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2021; 77(4):351-357. PubMed ID: 33883369
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Montemezzi S; Cavedon C; Camera L; Meliadò G; Caumo F; Baglio I; Sardanelli F
    Radiol Med; 2017 Mar; 122(3):161-170. PubMed ID: 27981485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Magnetic Resonance Spectroscopy at 3 T in Biopsy-Proven Breast Cancers: Does Choline Peak Correlate With Prognostic Factors?
    Galati F; Luciani ML; Caramanico C; Moffa G; Catalano C; Pediconi F
    Invest Radiol; 2019 Dec; 54(12):767-773. PubMed ID: 31356383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
    Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI and (1)H MRS of the breast: presence of a choline peak as malignancy marker is related to K21 value of the tumor in patients with invasive ductal carcinoma.
    Geraghty PR; van den Bosch MA; Spielman DM; Hunjan S; Birdwell RL; Fong KJ; Stables LA; Zakhour M; Herfkens RJ; Ikeda DM
    Breast J; 2008; 14(6):574-80. PubMed ID: 19000051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Elevated Choline on Magnetic Resonance Spectroscopy a Reliable Marker of Breast Lesion Malignancy?
    Prvulovic Bunovic N; Sveljo O; Kozic D; Boban J
    Front Oncol; 2021; 11():610354. PubMed ID: 34567998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
    Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
    Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.
    Sharma U; Agarwal K; Hari S; Mathur SR; Seenu V; Parshad R; Jagannathan NR
    Magn Reson Imaging; 2019 Sep; 61():66-72. PubMed ID: 31128225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
    Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
    Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-field MR spectroscopy in the multiparametric MRI evaluation of breast lesions.
    Cavedon C; Meliadò G; Rossi L; Camera L; Baglio I; Caumo F; Montemezzi S
    Phys Med; 2016 Dec; 32(12):1707-1711. PubMed ID: 27637861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of single voxel 1H MR spectroscopic imaging at 3T for the differentiation of benign and malign breast lesions.
    Ramazan A; Demircioglu O; Ugurlu U; Kaya H; Aribal E
    Clin Imaging; 2016; 40(5):831-6. PubMed ID: 27179154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions.
    Katz-Brull R; Lavin PT; Lenkinski RE
    J Natl Cancer Inst; 2002 Aug; 94(16):1197-203. PubMed ID: 12189222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators.
    Shin HJ; Baek HM; Cha JH; Kim HH
    AJR Am J Roentgenol; 2012 May; 198(5):W488-97. PubMed ID: 22528931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated analysis of the total choline resonance peak in breast proton magnetic resonance spectroscopy.
    Javor D; Bennani-Baiti BI; Clauser P; Kifjak D; Baltzer PAT
    NMR Biomed; 2024 Feb; 37(2):e5054. PubMed ID: 37794648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
    Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
    Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality fMRI with perfusion, diffusion-weighted MRI and
    Zhu L; Wang J; Shi H; Tao X
    J Magn Reson Imaging; 2019 Feb; 49(2):423-432. PubMed ID: 30475438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.